NIH Cuts, Which Way Will The Wind Blow?
By PAUL NATINSKY
Like the rest of the cuts by chainsaw, the 15-percent cap on indirect costs for National Institutes of Health projects is a sharp-edged reduction in spending. Purportedly targeted at reducing waste and inefficiency, the indiscriminate reduction belies that mission.
The most rudimentary of analyses would have proved the approach infeasible. About $9 billion of the NIH’s $35 billion in grants for 2023 were for indirect costs, which include equipment and office space, technology, research security, data processing, biosafety, financial and accounting support, and legal and compliance support. Indirect costs average around 28%, with some over 60%, according to NIH-reported numbers. The costs are negotiated on a project-by-project basis.
The proposed [Read More]